Andres Chang, MD, PhD
@ChangMDPhD
Followers
262
Following
123
Media
21
Statuses
107
Assistant Professor, Hematology and Medical Oncology @EmoryUniversity, @EmoryMedicine, @WinshipAtEmory Specializing in lymphoid malignancies. Opinions = my own
Atlanta, GA
Joined December 2018
Check out our latest review with @zach_buchwald on the importance of having a diverse population in immune checkpoint therapy trials! The field has come a long way but lots more to do. @WinshipAtEmory.
jitc.bmj.com
Immune checkpoint blockade (ICB) therapies are one of the greatest advances in the history of cancer care and are now commonly used in the management of many different malignancies. However, much...
2
0
8
Ready to show little kids @GLOBEAcademy about the fun field of #hematology! Thank you @ASH_hematology, @LLSusa, and @WinshipAtEmory for supporting this effort!
0
0
4
RT @CllSociety: Today is #WorldCLLDay! Join us to raise awareness & advocate for equal care for those with chronic lymphocytic leukemia (#C….
0
5
0
Humbled and grateful to be a recipient of an ASH Scholar! @ASH_hematology @WinshipAtEmory.
Congrats to Winship hematologist Andres Chang, MD, PhD for being one of 36 recipients of the American Society of Hematology (@ASH_hematology) 2024 Scholar Awards. ➡️ Press Release:
2
0
15
RT @WinshipAtEmory: Winship researcher Andres Chang, MD, PhD (@ChangMDPhD) received a three-year, $150,000 Young Investigator Award from @C….
cllsociety.org
The Young Investigator Award is to help to grow and develop a new generation of researchers who are committed to solving the unmet needs of the disease.
0
5
0
Congrats to @ChangMDPhD from @WinshipAtEmory.for being the recipient of CLL Society's 2023 Young Investigator Award! Dr. Chang’s #research will look at why #CLL pts have a poorer response to #COVID19 vaccination, specifically considering the B-cells.
2
0
17
Low neutralizing activity of AZD7442 against current SARS-CoV-2 Omicron variants in patients with B cell malignancies
ashpublications.org
TO THE EDITOR:
0
0
2
Excited to share our latest study looking at #CovidVaccine booster in #NHL and #CLL patients. #SeroNet. @WinshipAtEmory @rafiahmed_lab @JeanKoffMD @PamAllenMD1 @jonathonbcohen @SutharLab @MadhavDhodapkar .
2
4
16
Congratulations to my #TRTH classmate @FSchererMD! @ASH_hematology. ctDNA can be very useful in the diagnosis and monitoring of PCNSL .Circulating Tumor DNA Profiling for Detection, Risk Stratification, and Classification of Brain Lymphomas
ascopubs.org
PURPOSEClinical outcomes of patients with CNS lymphomas (CNSLs) are remarkably heterogeneous, yet identification of patients at high risk for treatment failure is challenging. Furthermore, CNSL...
1
5
15
Congrats to @SutharLab @EmoryVaccineCtr for this important and timely paper! Bivalent boosters generate better neutralizing abs vs contemporary variants. Neutralization against BA.2.75.2, BQ.1.1, and XBB from mRNA Bivalent Booster | NEJM
nejm.org
One or two monovalent vaccine boosters showed a large decrease in neutralization activity against omicron subvariants. The BA.5-containing bivalent booster improved neutralizing activity against al...
0
0
5
So happy that we got to have a mini #TRTH reunion #ASH22! @crabik47 @YangDing19 @HeideggerS_MD @MariellaVeglia1 @paulmaciocia
0
0
12
Congratulations Dr. Flowers for the ASH mentor award! Very well deserved! Very thankful for your continued mentorship! #ASH22
1
0
13
0
1
6
0
0
16
Generate videos in just a few seconds. Try Grok Imagine, free for a limited time.
398
661
3K